Literature DB >> 21927015

Proinflammatory IL-17 induces iBALT development.

Mingzhao Zhu1, Yangxin Fu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21927015      PMCID： PMC4002805          DOI： 10.1038/cmi.2011.46

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  11 in total

1.  Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity.

Authors:  Juan E Moyron-Quiroz; Javier Rangel-Moreno; Kim Kusser; Louise Hartson; Frank Sprague; Stephen Goodrich; David L Woodland; Frances E Lund; Troy D Randall
Journal:  Nat Med       Date:  2004-08-15       Impact factor: 53.440

Review 2.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 3.  Lymphoid organ development: from ontogeny to neogenesis.

Authors:  Danielle L Drayton; Shan Liao; Rawad H Mounzer; Nancy H Ruddle
Journal:  Nat Immunol       Date:  2006-04       Impact factor: 25.606

Review 4.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

5.  An unexpected role for IL-17 in lymphoid organogenesis.

Authors:  Tom Cupedo
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

Review 6.  Interleukin-17 and its expanding biological functions.

Authors:  Sheng Xu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

7.  Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Xiaohuan Guo; Yugang Wang; Andrei Kruglov; Sergei Nedospasov; Yang-Xin Fu
Journal:  Cell Host Microbe       Date:  2011-07-21       Impact factor: 21.023

Review 8.  Lymphoid neogenesis in chronic inflammatory diseases.

Authors:  Francesca Aloisi; Ricardo Pujol-Borrell
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

Review 9.  IL-17-producing T cells in lung immunity and inflammation.

Authors:  Chiara Nembrini; Benjamin J Marsland; Manfred Kopf
Journal:  J Allergy Clin Immunol       Date:  2009-05       Impact factor: 10.793

10.  The development of inducible bronchus-associated lymphoid tissue depends on IL-17.

Authors:  Javier Rangel-Moreno; Damian M Carragher; Maria de la Luz Garcia-Hernandez; Ji Young Hwang; Kim Kusser; Louise Hartson; Jay K Kolls; Shabaana A Khader; Troy D Randall
Journal:  Nat Immunol       Date:  2011-06-12       Impact factor: 25.606
View more
  3 in total

1.  Genetic Background Affects the Mucosal Secretory IgA Levels, Parasite Burden, Lung Inflammation, and Mouse Susceptibility to Ascaris suum Infection.

Authors:  Luciana Maria Oliveira; Denise Silva Nogueira; Ricardo Marcelo Geraldi; Fernando Sérgio Barbosa; Chiara Cássia Oliveira Amorim; Ana Clara Gazzinelli-Guimarães; Nathália Maria Resende; Natália Pinheiro-Rosa; Lucas Rocha Kraemer; Matheus Silvério Mattos; Lilian Lacerda Bueno; Ana Maria Caetano Faria; Remo Castro Russo; Soraya Gaze; Ricardo Toshio Fujiwara
Journal:  Infect Immun       Date:  2021-11-22       Impact factor: 3.609

2.  Blomia tropicalis-Specific TCR Transgenic Th2 Cells Induce Inducible BALT and Severe Asthma in Mice by an IL-4/IL-13-Dependent Mechanism.

Authors:  Yen Leong Chua; Ka Hang Liong; Chiung-Hui Huang; Hok Sum Wong; Qian Zhou; Say Siong Ler; Yafang Tang; Chin Pei Low; Hui Yu Koh; I-Chun Kuo; Yongliang Zhang; W S Fred Wong; Hong Yong Peh; Hwee Ying Lim; Moyar Qing Ge; Angela Haczku; Veronique Angeli; Paul A MacAry; Kaw Yan Chua; David M Kemeny
Journal:  J Immunol       Date:  2016-10-12       Impact factor: 5.422

Review 3.  Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together.

Authors:  Gareth W Jones; David G Hill; Simon A Jones
Journal:  Front Immunol       Date:  2016-10-03       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.